ViralHep_GR_Perelman_www2012_v2.jpg 
Jointly provided by the Perelman School of Medicine at the University of Pennsylvania and ViralEd, Inc.

Perelman School of Medicine Small JPEG                                                          VE logo 300px

Speaker: Marina Serper, MD
Time: Wednesday, November 29, 2017 at 12:00PM EST
Topic: Real Cases from the University of Pennsylvania


Be sure to read through the program overview prior to registering and attending this program.

Scroll down to access the program registration/Log-in window at the bottom of the page.


Series Overview:

The Perelman School of Medicine at the University of Pennsylvania and ViralEd are proud to announce the Viral Hepatitis Grand Rounds. This program is based on the ground-breaking CME activity HIV Grand Rounds that, in partnership with the Perelman School of Medicine at the University of Pennsylvania, has successfully run for several years. These CME-certified sessions combine traditional academic grand rounds with the innovation and convenience of telemedicine. The Viral Hepatitis Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania is delivered live via the Internet two Wednesday's each month at 12:00 pm Eastern Time and are available for on-demand viewing immediately following the live broadcast.

Presentations cover the most important and current topics in hepatitis and are delivered by the top experts in the field. They are designed to be immediately relevant to practicing hepatitis clinicians and many are case-based. The final 10 minutes of each one-hour educational activity consists of a live question and answer period, with the presenting faculty member available to answer questions asked by attendees using the webinar interface. These monthly grand rounds are intended to provide clinicians with convenient and easily accessible knowledge and clinical skills they need to provide the best medical care for their Hepatitis patients.

Each session may be broadcast via your Internet connection in your conference room or auditorium for large groups to view, or individually to your personal computer at your convenience. Simply register at www.viraled.com/hepatitisgrandrounds for easy access.

Target Audience:

This program has been designed for physicians, fellows, residents, medical students, physician assistants, pharmacists, professional nurses, advanced practice nurses, and nursing students in dermatology, family medicine, internal medicine, obstetrics and gynecology, pediatrics, psychiatry and neurology.

Commercial Support Acknowledgement:

These activities are supported by educational grants from Gilead Sciences Medical Affairs, and Merck & Co., Inc.

Series Educational Objectives:

Upon completion of the program, participants should be able to:

  • Demonstrate increased understanding of the epidemiology of and risk factors for viral hepatitis;
  • Increase the rate of testing of viruses associated with hepatitis;
  • Demonstrate improved knowledge, competence and clinical practice in terms of the current standards and guidelines for the management of patients with viral hepatitis;
  • Demonstrate an improved understanding of the treatment of viral hepatitis in patients co-infected with HIV or other viral infections


SeSSION Educational Objectives:

Upon completion of the program, participants should be able to:

  • Identify viral causes of acute liver failure
  • Recognize extra-hepatic manifestations of hepatitis C virus
  • Explain the management of extra-hepatic manifestations of hepatitis C virus

Course Directors:

 K. Rajender Reddy MD

K. Rajender Reddy, MD

Ruimy Family President's Distinguished Professor of Medicine
Professor of Medicine in Surgery Director of Hepatology
Director, Viral Hepatitis Center
Medical Director, Liver Transplantation
University of Pennsylvania
Philadelphia, Pennsylvania 

   
Ian Frank, MD UPenn

Ian Frank, MD

Professor of Medicine
Director, Clinical Therapeutics Program
Penn Center for AIDS Research
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

      David E. Kaplan, MD MSc UPenn               

David E. Kaplan, MD, MSc

Assistant Professor of Medicine
Division of Gastroenterology 
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

Program Faculty:

 Serper, Marina

Marina Serper, MD, MS


Assistant Professor of Medicine
Hospital of the University of Pennsylvania
Instructor of Medicine
University of Pennsylvania Perelman School of Medicine
Philadelphia, Pennsylvania

                         

 

Accreditation:

The activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Perelman School of Medicine at the University of Pennsylvania and ViralEd, Inc. The Perelman School of Medicine at the University of Pennsylvania is accredited by the ACCME to provide continuing medical education for physicians.

Designation of Credit:

Physicians:The Perelman School of Medicine at the University of Pennsylvania designates this live activity for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PAs: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1 Category 1 credits for completing this activity.

Disclosures:

It is policy at the Perelman School of Medicine at the University of Pennsylvania and the Hospital of the University of Pennsylvania, Department of Nursing Education, Innovation and Professional Development for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provide products or services that may be relevant to the content of this continuing education activity. For this purpose we consider relationships of the person involved to include financial relationships of a spouse or partner.

The intent of this policy is to ensure that Penn CME/CNE certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information was found to contain relationships that created a conflict of interest relevant to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.

The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania, Mila Kostic, CHCP, FACEHP, Director of CME, Zalman Agus, MD, Senior peer reviewer and Patricia A. Smith, DNP, RN-BC, Nursing professional development specialist of the HUP Department of Nursing Innovation and Development have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity.

The following faculty members have reported NO relevant financial relationships with commercial interests related to the content of this educational activity:

  Marina Serper, MD; Brian Boyle, Rick Gordon, Oliver Fultz, Mila Kostic, CHCP, FACEHP

Faculty/Course Director Disclosures: 
K. Rajender Reddy, MD Gilead, Abbvie, Merck Advisorty Board
  Gilead, Abbvie, Merck, BMSk Janssen

Research Grant

David Kaplan MD

Bayer Pharmaceutical & Inovio Pharmaceuticals

Contracted Research

   

         

      Ian Frank, MD

      Gilead; BMS; Merck; Janssen

      Advisor; Honorarium

        GlaxoSmithKline

      Contracted Research

Discussion of Investigational and/or Off-label Use of commercial products and devices:

The Perelman School of Medicine at the University of Pennsylvania Requires all faculty to disclose any discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation.  Participants should note that the use of products outside FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.

Faculty members will disclose to participants any discussions of off-label and/or investigational uses of pharmaceutical products within their presentations.

Disclaimer:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

register/View:

Viral Hepatitis Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania: Wednesday, November 29, 2017
Your name *
Email address *
Degree/Profession *
Country *
How many participants are watching using your internet connection? *
 
* Required